Andrew Booth - 12 May 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Financial Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
12 May 2022
Net transactions value
+$492,150
Form type
4
Filing time
16 May 2022, 14:13:24 UTC
Previous filing
03 Feb 2022
Next filing
05 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $492,150 +85,000 +159% $5.79 138,500 12 May 2022 Direct
holding ABCL Common Shares 130,959 12 May 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.